Hints and tips:
Related Special Reports
...German drugs and crop science conglomerate Bayer has postponed a decision on whether to break itself up, as it launches a €2bn cost-cutting plan and promises to bring down debt....
...Despite that, the company has taken steps to end the protracted crisis over Roundup, which Bayer acquired as part of its ill-fated $63bn acquisition of US crop sciences business Monsanto in 2016....
...He added that the underlying operative problems in the pharma and crop science businesses needed to be addressed without undue job cuts....
...The company, which has been under pressure from investors to break itself up, is still struggling with the damage from its $63bn takeover of US crop sciences group Monsanto in 2016....
...Bayer is under pressure from shareholders as it is reeling from the $63bn acquisition of US crop science giant Monsanto....
...from the crop sciences business....
...Bayer last week abandoned a trial of blood-thinner asundexian after it did not work as hoped to treat heart disease....
...Bayer also took a €4bn impairment charge on the value of its crop science assets, adding to a €2.3bn writedown in the second quarter....
...The seas are rising, AI deepfakes are proliferating, the population is ageing and environmental degradation is setting the scene for fresh pandemics....
...Crop science is the largest part of the business and would work as a standalone. There is also a case for splitting off pharma, which would be worth about €33bn....
...So with its mushrooming courtroom losses, Bayer is trying a new strategy by going state by state in the US to get legislation passed that would say the Environmental Protection Agency’s rules for pesticides...
...Last month he blasted Bayer’s performance as “unacceptable” and stressed that “all options” were on the table, including splitting the pharma unit from the crop science division....
...Bayer has had to pay out billions of dollars after juries in litigation that was also led by Wisner found a link between a weedkiller developed by Monsanto, the US company the German group acquired in 2018...
...The writer is a science commentator It was Earth Day on Monday, an annual reminder of our duty to look after the climate and environment for future generations. By any measure, we are failing....
...They favour a spinout of the crop science unit, a business that troubles environmental, social and governance investors. That would make sense....
...Its reputation hinges on the perception that its decisions are based on rigorous, science-based research — not made privately and unilaterally by its nine board members....
...Shares in Bayer, the EU’s biggest pesticide producer, have risen more than 5 per cent since the announcement....
...The writer is a science commentator The recipe for becoming a science and technology superpower involves more than simply excelling at science and technology....
...AstraZeneca’s transformation is the sort of turnaround that others in the sector, such as Germany’s Bayer, need to replicate....
...Urban growth is driving environmental change at an unprecedented scale....
...science superpower” by 2030....
...Azole resistance levels vary around the world but are typically 10-20 per cent in environmental samples of Aspergillus from northern Europe....
...Surprisingly, in part of the Bayer case, the trial attorneys have actually been acting on behalf of allegedly injured parties against the US Environmental Protection Agency, accusing the EPA of approving...
...Big share price moves in Europe today include UK-based equipment rental group Ashtead, German life sciences company Bayer and British mobile phone reseller MusicMagpie: Ashtead: Shares in the FTSE 100-listed...
...Responsibility for remediating former mine sites belongs to environmental regulators Natural Resources Wales and the Environment Agency....
International Edition